Full Disclosure

Open Enrollment season is right around the corner, bringing a familiar storm of tight deadlines, employee confusion, and administrative headaches for HR teams. Delivering a seamless experience while balancing cost containment and member satisfaction is enough to strain any benefits team. Prioritizing employee trust and plan performance requires a clear, proactive strategy.

Join Rena Cater, Vice President of Human Resources at Eagle Transport, for a practical look into executing a low-stress, high-impact Open Enrollment strategy. You’ll learn how real-world benefit leaders navigate PBM transitions, drive employee engagement with non-elective pharmacy benefits, and leverage partner support to streamline operations.

In this episode, we explore:

• How to build an actionable Open Enrollment (OE) timeline that reduces friction
• Best practices for evaluating PBM partners through the lens of OE support
• Key strategies to educate employees on non-elective benefits during OE

Thank you to our guest, Rena Cater, Vice President of Human Resources at Eagle Transport.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

Everywhere you turn, there’s news about GLP-1s: soaring costs, rising demand, and new approved indications and drugs coming to market. It’s enough to make any benefit leader’s head spin. Prioritizing member outcomes and plan sustainability requires being armed with the truth; not just press buzz.

Join Obesity Medicine Association member, Elena Sullivan, PA-C, for a look into what’s changed with the GLP-1 market in the last year, what’s coming, and how you can leverage clinical insights to make responsible decisions for your plan’s long-term sustainability.

In this episode, we explore:

• What new GLP-1 drugs have come to market, and what’s in the pipeline
• The science behind treating obesity as a chronic disease state
• How establishing the right benefits partnerships are crucial for clinically-informed coverage

Thank you to our guest, Elena Sullivan, PA-C from the Obesity Medicine Association.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

In an industry dominated by complex pharmacy benefit contracts, it can be nearly impossible for folks without a law degree to decipher what deals (and rights) they get in their PBM contract. But what if you could simply take an x-ray to your contract and get clear takeaways on the value it delivers?

Join Nautilus Health’s Steven Ditto as he breaks down the new tools available to plan sponsors that help put them in control of their PBM contracts.

In this episode, experts discuss:

• Understanding the gap between PBM jargon and true fiduciary commitment
• A guided look at Nautilus Health’s Contract X-ray and CAA Readiness Report
• Questions to ask your PBM to verify real compliance versus marketing tactics

Thank you to our guest, Steve Ditto, Board Advisor at Nautilus Health.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

Fragmented care leads to fragmented results. In this session, leaders from SmithRx and Transcarent discuss how a centralized engagement hub is crucial for reducing patient fatigue and boosting results for businesses and members. Learn how a single-entry point for healthcare and pharmacy benefits navigation drives higher engagement, better clinical outcomes, and lower total cost of care.

In this episode, experts discuss:

• How a unified experience increases member engagement and improves outcomes.
• Why native integrations drive clinical adherence and reduce wasteful employer spend. 
• How a more interconnected, ‘real-time’ future will empower support staff and meaningfully enhance the member experience.

Thank you to our guest, Dr. Jonathan Koval, SVP & GM, Transcarent.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

Why are pharmacy costs skyrocketing while the local pharmacies your employees rely on are closing at record rates? Big healthcare and legacy PBMs are to blame. As the largest PBMs tighten their grip on the supply chain, the movement to Break Up Big Medicine is gaining federal and state-level momentum. Supporting pharmacy sustainability is a financial necessity for the modern health plan.

Join SmithRx’s Senior Clinical Strategy Director, Dr. Alissa Johnson, PharmD, and independent pharmacy advocate Dr. Benjamin Jolley, PharmD, for a deep dive into the legislative battlegrounds (from D.C. to Tennessee) and what the survival of community pharmacy means for your plan’s long-term economics.

In this episode, we explore:

• How predatory PBM contracts create pharmacy deserts that worsen health outcomes
• Bills breaking up big health and why PBMs are spending millions to stop them
• How research proves restructuring PBM incentives can drastically lower spend

Thank you to our guest, Dr. Benjamin Jolley, PharmD.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

2026 has shaken the PBM industry to its core. The businesses that take full advantage of this new era of pharmacy benefits are the ones who get ahead of market shifts and evaluate current, and future, PBM partnerships critically. Are you prepared? Join Mercer’s Senior Principal, Debbie Doolittle, and SmithRx’s Senior Director of Clinical Strategy, Alissa Johnson, for a deep dive into structuring a pharmacy benefits Request for Proposal (RFP) that prioritizes transparency and long-term value.

In this episode, we explore how to:

• Build out a hyper-effective, cross-functional benefits committee
• Map the RFP journey from initial evaluation to a successful go-live
• Compare legacy, discount-focused models against modern, cost-focused ones

Thank you to our guest, Debbie Doolittle.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

In a market where transparency is now a legal mandate rather than a marketing buzzword, how do you distinguish between PBMs that are merely complying on paper and those that are truly innovating and aligning with clients? It starts with a deep understanding of the newest passed (and proposed) legislation and modern PBM models that are already one step ahead.

Join SmithRx’s Chief Strategy Officer, Alan Pannier, for an executive analysis of the most recent federal legislation and regulations, the rise of direct-to-consumer (DTC) platforms, what they mean for your plan spend, and the insights your plan needs to thrive in a “post-rebate” era.

In this episode, we explore:

• Why CAA 2026 makes pharmacy benefits oversight your fiduciary responsibility
• How direct-to-consumer portals can be a helpful fact-checking mechanism
• Which PBM models will thrive in a “no-middleman” benefits future

Thank you to our guest, Alan Pannier.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

HR and benefits leaders today face a stark reality: you either have total control over your pharmacy spend, or you have none. As legacy, and some pass-through, models struggle to adapt to regulatory pressure and rising costs, how can employers distinguish between PBMs that are merely rebranding old tactics and those that have fundamentally re-engineered the cost-containment engine?

Join SmithRx experts Alissa Johnson, Vidya Drego, and Ty Perry for a candid breakdown of the market shifts requiring a new breed of PBM. From the "budgets vs. member experience" dilemma to the technical evolution of cost containment solutions, we explore how the Drug Pathways Engine is here to future-proof your benefits plan.

In this episode, we explore:

• What trends today are shaping the PBM landscape and why its reached a boiling point
• Why making the leap to a modern PBM has unprecedented ROI
• How SmithRx has engineered an innovative solution for sustainable savings improvements

Thank you to our guests, Vidya Drego and Ty Perry.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

Innovation is the only way forward for sustainable pharmacy benefits that actually put people and plans first. In a market rife with hype and false promises of transparency and transformation, how do you separate the innovators from the imitators? It starts with understanding the fundamentals of how advancements like AI can be applied to optimize plan success.

Join SmithRx’s Gaston Concilio for a deep dive into the technology powering the next gen of pharmacy benefits and member experiences.

In this episode, we explore:

• How AI can make complex documentation digestible for patients
• Ways AI empowers more empathetic and efficient care
• Why legacy vendors won’t be able to keep up in the age of AI

Thank you to our guest, Gaston Concilio, SVP of Engineering at SmithRx.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv

Navigating pharmacy benefits in 2026 requires balancing complex compliance with rising fiscal pressure. Is your PBM contract truly engineered for alignment? Join us as we sit down with leading fiduciary advocate Ann Lewandowski to tackle the year’s most critical pharmacy trends and the essential tips for spotting misalignment red flags.

In this episode, we cover:

• How to spot true fiduciary alignment in your partners
• Potential risks of missing out on low-cost biosimilars
• Strategies you can use to manage GLP-1 costs while remaining compliant

Thank you to our guest, Ann Lewandowski, MLS, Fiduciary Advocate.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv